Frontiers | Biomarkers of Immunotoxicity from Immune Checkpoint Inhibitors

Biomarkers of Immunotoxicity from Immune Checkpoint Inhibitors

9,788
Total downloads
28k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 09 Jan 2025

Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort study

Yoshihiko Tasaki
Shuzo Hamamoto
Shimpei Yamashita
Junya Furukawa
Kazutoshi Fujita
Ryotaro Tomida
Makito Miyake
Noriyuki Ito
Hideto Iwamoto
5 more
Yoko Furukawa-Hibi

doi 10.3389/fimmu.2024.1483956

1,230 views

REVIEW

Published on 11 Dec 2024

Advances in biomarkers for immunotherapy in small-cell lung cancer

Hui Li
Peiyan Zhao
Lin Tian
Yuanhua Lu
Xinyue Wang
Wenjun Shao
Ying Cheng

doi 10.3389/fimmu.2024.1490590

821 views

CASE REPORT

Published on 22 Nov 2024

Clinical characteristics and biomarkers of severe immune checkpoint inhibitor-related pneumonitis triggered by immunotherapy followed by radiation: a case report

Yan Zhu
Jianhe Yu
Qun Ren
Xiang Wu
Hongxia Xu
Tian Tian
Jiang Liu

doi 10.3389/fimmu.2024.1454114

657 views

ORIGINAL RESEARCH

Published on 10 Oct 2024

Biomarkers in the early stage of PD-1 inhibitor treatment have shown superior predictive capabilities for immune-related thyroid dysfunction

Jinyu Liu
Mengli Chen
Shu Li
Le Cai
Liang Ma
Qiuliang Yang
Xiaoxuan Zhang
Nan Bai
Xiaodong Wu
1 more
Tianlin Wang

doi 10.3389/fimmu.2024.1458488

779 views

SYSTEMATIC REVIEW

Published on 23 Sep 2024

Neutrophil-to-lymphocyte ratio as a predictive biomarker for hyperprogressive disease mediated by immune checkpoint inhibitors: a systematic review and meta-analysis

Bo Pei
Jue Zhang
Lin Lai
Hui Chen

doi 10.3389/fimmu.2024.1393925

756 views

REVIEW

Published on 23 Aug 2024

Toxicity in the era of immune checkpoint inhibitor therapy

Synat Keam
Naimah Turner
Fernanda G. Kugeratski
Rene Rico
Jocelynn Colunga-Minutti
Rayansh Poojary
Sayan Alekseev
Anisha B. Patel
Yuanteng Jeff Li
8 more
Roza Nurieva

doi 10.3389/fimmu.2024.1447021

3,224 views

ORIGINAL RESEARCH

Published on 25 Jun 2024

The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients

Ni Sun
Ru Li
Haiyi Deng
Qingyang Li
Jiaxi Deng
Yue Zhu
Wenwei Mo
Wenhui Guan
Minjuan Hu
3 more
Chengzhi Zhou

doi 10.3389/fonc.2024.1372532

734 views

ORIGINAL RESEARCH

Published on 16 Apr 2024

Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice

Mitchell S. von Itzstein
Yuqiu Yang
Yiqing Wang
David Hsiehchen
Thomas Y. Sheffield
Farjana Fattah
Vinita Popat
Murtaza Ahmed
Jade Homsi
7 more
David E. Gerber

doi 10.3389/fimmu.2024.1351739

924 views

REVIEW

Published on 15 Mar 2024

Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients

Abdullah Al-Danakh
Mohammed Safi
Yuli Jian
Linlin Yang
Xinqing Zhu
Qiwei Chen
Kangkang Yang
Shujing Wang
Jianjun Zhang
Deyong Yang

doi 10.3389/fimmu.2024.1348189

2,445 views
4 citations

REVIEW

Published on 05 Feb 2024

Immune checkpoint inhibitors associated cardiovascular immune-related adverse events

Wonyoung Jo
Taejoon Won
Abdel Daoud
Daniela Čiháková

doi 10.3389/fimmu.2024.1340373

5,465 views
4 citations

ORIGINAL RESEARCH

Published on 29 Jan 2024

Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy

Michael J. Dennis
Sophia Bylsma
Lisa Madlensky
Meghana S. Pagadala
Hannah Carter
Sandip P. Patel

doi 10.3389/fimmu.2024.1322187

1,137 views

ORIGINAL RESEARCH

Published on 29 Jan 2024

The impact of pulmonary artery to ascending aorta diameter ratio progression on the prognosis of NSCLC patients treated with immune checkpoint inhibitors

Bingxin Gong
Yi Li
Yusheng Guo
Jing Wang
Weiwei Liu
Guofeng Zhou
Jiyu Song
Feng Pan
Lian Yang
Bo Liang

doi 10.3389/fimmu.2024.1302233

1,012 views

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Impact

28kTopic views
18kArticle views
9,788Article downloads

View impact

Submit your idea

Articles

Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort study

Advances in biomarkers for immunotherapy in small-cell lung cancer

Clinical characteristics and biomarkers of severe immune checkpoint inhibitor-related pneumonitis triggered by immunotherapy followed by radiation: a case report

Biomarkers in the early stage of PD-1 inhibitor treatment have shown superior predictive capabilities for immune-related thyroid dysfunction

Neutrophil-to-lymphocyte ratio as a predictive biomarker for hyperprogressive disease mediated by immune checkpoint inhibitors: a systematic review and meta-analysis

Toxicity in the era of immune checkpoint inhibitor therapy

The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients

Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice

Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients

Immune checkpoint inhibitors associated cardiovascular immune-related adverse events

Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy

The impact of pulmonary artery to ascending aorta diameter ratio progression on the prognosis of NSCLC patients treated with immune checkpoint inhibitors

Frontiers in Immunology

Participating Journals

Impact